Aod9604 5MG
$119.00
Aod9604 5MG is a 5-milligram format of AOD9604, a synthetic peptide analogue based on the human growth hormone fragment 176 191. Researchers study it for its potential role in metabolism and lipolysis related pathways in preclinical models. Studies have also examined AOD9604 in the context of adipose tissue signaling and body composition research.
In Stock
Aod9604 5MG is a 5-milligram format of AOD9604, a synthetic peptide analogue modeled on the C terminal region of human growth hormone corresponding to residues 176 191. It is commonly referenced in the literature as an hGH fragment analogue and is used in laboratory work where investigators compare fragment based sequences to full length endocrine peptides.
Researchers study Aod9604 5MG for its potential role in metabolic regulation research, including preclinical investigations of lipolysis associated pathways and adipocyte biology. Studies have examined AOD9604 in relation to signaling markers tied to fat metabolism, with outcomes dependent on model design, dose, and assay conditions.
- Specification: 5MG
This product is intended for laboratory and research purposes only. Not for human consumption.
| Weight | 0.2 kg |
|---|---|
| Dimensions | 5 × 5 × 5 cm |
Related Products
Semaglutide 30MG is a 30-milligram format of semaglutide, a synthetic GLP-1 receptor agonist peptide analogue. Researchers study semaglutide in the context of incretin signaling, glucose regulation pathways, and appetite related neuroendocrine models. It is a modified peptide designed to extend stability relative to native GLP-1.
In Stock
Tirzepatide 15MG is a 15-milligram format of tirzepatide, a synthetic peptide studied as a dual agonist at the GIP and GLP 1 receptors. It is of interest in metabolic and endocrine research where incretin signaling is examined. Studies have evaluated tirzepatide in preclinical and clinical settings to better understand receptor bias, signaling kinetics, and downstream biomarker changes.
In Stock
Semaglutide 10MG is a 10-milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. Researchers study semaglutide in receptor pharmacology and metabolic signaling research, including models examining appetite regulation and glucose homeostasis. It is also used in assay development and method validation where GLP 1 pathway engagement is of interest.
In Stock
Trenbolone Enanthate 250Mg; Drostanolone Enanthate 250Mg – 500mg/ml, 10ml is a combined format of two anabolic androgenic steroid esters: trenbolone (a 19 nor testosterone derivative) and drostanolone (a DHT derived analogue). Researchers may reference these compounds in studies involving androgen receptor signaling, esterified steroid pharmacokinetics, and analytical method development. Work in the literature commonly discusses trenbolone and drostanolone in the context of endocrine pathways and structure activity relationships.
In Stock
Semaglutide 20MG is a 20 milligram format of semaglutide, a synthetic GLP 1 receptor agonist peptide analogue. It is a 31 amino acid peptide modified for extended stability, and it is widely used in laboratory work involving incretin signaling and metabolic regulation. Researchers study semaglutide in preclinical and translational settings related to glucose homeostasis, appetite pathways, and receptor pharmacology.
In Stock
Cagrilintide + Semaglutide 5MG is a 5-milligram combined format of two peptide research compounds: cagrilintide (an amylin analogue) and semaglutide (a GLP 1 receptor agonist peptide analogue). Researchers study this pairing in preclinical and clinical research settings focused on appetite regulation and metabolic signaling. Studies have examined how amylin and GLP 1 pathways may interact when investigated together.
In Stock
Superdrol / Methyldrostanolone 50mg/ml, 10ml refers to a defined concentration and volume format of methyldrostanolone, a 17 alpha alkylated synthetic anabolic androgenic steroid related to dihydrotestosterone analogues. Researchers have examined methyldrostanolone in studies of androgen receptor activity and anabolic androgenic structure activity relationships.
In Stock
Trenbolone Acetate 75Mg; Trenbolone Enanthate 75Mg; Trenbolone Hexahydrobenzylcarbonate (Parabolan) 75Mg – 200mg/ml, 10 ml is a multi ester trenbolone preparation specified at 200 mg per mL in a 10 mL format. Trenbolone is a synthetic anabolic androgenic steroid derived from 19 nortestosterone, and researchers may use it when studying androgen receptor signaling and steroid structure activity relationships. Work in preclinical and analytical settings has examined trenbolone esters for differences in lipophilicity, hydrolysis rates, and detection profiles.
In Stock
Tirzepatide 20MG is a 20-milligram format of tirzepatide, a synthetic peptide studied as a dual GIP and GLP 1 receptor agonist. Researchers examine tirzepatide in metabolic research, including models related to glycemic regulation, appetite signaling, and energy balance.
In Stock
Tirzepatide 10MG is a 10-milligram format of tirzepatide, a synthetic peptide investigated as a dual GIP and GLP 1 receptor agonist in metabolic research. Studies have examined tirzepatide in the context of incretin signaling, glycemic physiology, and energy balance pathways.
In Stock
Winstrol 100mg/ml 10ml refers to a 100 milligram per millilitre concentration supplied in a 10 millilitre format of stanozolol, a synthetic anabolic androgenic steroid derived from dihydrotestosterone. Researchers may reference stanozolol in studies involving androgen receptor signaling, anabolic steroid structure activity relationships, and metabolism profiling.
In Stock
Trenbolone Enanthate (Tre) 200mg/ml 10ml is a concentration and volume format of trenbolone enanthate, a synthetic anabolic androgenic steroid and esterified analogue of trenbolone. Researchers may use trenbolone esters in laboratory work involving androgen receptor signaling, steroid metabolism, and analytical reference testing.
In Stock
